Loading…
Vericel Corporation is projected to rise to $71.40 by 2027, a +50% move from its current price of $47.61. VCEL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $46.76 | $47.65 | $48.56 | +0.09% |
| Aug 2 | $46.43 | $47.69 | $48.99 | +0.18% |
| Aug 3 | $46.20 | $47.74 | $49.33 | +0.27% |
| Aug 4 | $46.00 | $47.78 | $49.62 | +0.35% |
| Aug 5 | $45.84 | $47.82 | $49.89 | +0.44% |
| Aug 6 | $45.69 | $47.86 | $50.13 | +0.53% |
| Aug 7 | $45.57 | $47.91 | $50.37 | +0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $45.57 | $47.91 | $50.37 | +0.62% |
| Week 2 | $44.91 | $48.20 | $51.74 | +1.25% |
| Week 3 | $44.47 | $48.50 | $52.90 | +1.87% |
| Week 4 | $44.15 | $48.80 | $53.94 | +2.51% |
| Week 5 | $43.90 | $49.11 | $54.92 | +3.14% |
| Week 6 | $43.71 | $49.41 | $55.86 | +3.78% |
| Week 7 | $43.55 | $49.72 | $56.76 | +4.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vericel Corporation is a commercial-stage biopharmaceutical company focused on cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc.
and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
Vericel Corporation (VCEL) is trading at $45.32 and is positioned as a healthcare stock focused on cellular therapies and burns care in North America. Its market capitalization is $2.31B and it is ranked 1834 by market metrics. The current price sits at the level of the 2026 forecast average, with a long-run outlook showing meaningful upside across multiple years.
A major floor 38.4% below — a decisive break under it would weaken the trend.
The nearest floor, 17.8% below — buyers have tended to step in here.
Price is pressing into resistance (1.5% away) — a breakout level to watch.
A major ceiling 13.8% above — clearing it would confirm fresh momentum.
Key VCEL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VCEL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $46.26 | Buy | $46.59 | Buy |
| MA 10 | $45.96 | Buy | $46.28 | Buy |
| MA 20 | $46.53 | Buy | $45.58 | Buy |
| MA 50 | $41.39 | Buy | $42.54 | Buy |
| MA 100 | $37.54 | Buy | $39.87 | Buy |
| MA 200 | $37.33 | Buy | $38.71 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.50 | Neutral |
| Stoch RSI (14) | 59.80 | Neutral |
| CCI (20) | 95.28 | Neutral |
| Williams %R (14) | -6.15 | Info |
| MACD (12,26,9) | -0.29 | Sell |
| ROC (12) | 3.30 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 93.85 | Sell |
| TRIX (15) | 0.54 | Buy |
| Awesome (5,34) | 1.88 | Buy |
| Ultimate (7,14,28) | 61.73 | Neutral |
| Momentum (10) | -0.20 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 47.03 | Buy |
| ADX (14) | 26.26 | Buy |
| ATR (14) | 0.79 | Info |
The near-term technical picture is bullish in sentiment, with RSI 14 at 50. The stock sits above the 50-day moving average of $40.35 and above the 200-day moving average of $37.06, signaling constructive price action. Near-term support is at $37.46, with resistance at $48.31.
The 30-day price range spans from $39.78 to $51.64, illustrating a trading band in the high-$40s to low-$50s.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.34 | $47.61 | $67.86 | 0% | Neutral | |
| $58.52 | $71.40 | $91.03 | +50% | Bullish | |
| $64.13 | $79.73 | $104.46 | +67% | Bullish | |
| $76.88 | $97.07 | $129.93 | +104% | Bullish | |
| $84.28 | $107.87 | $147.01 | +127% | Bullish | |
| $89.76 | $116.31 | $161.04 | +144% | Bullish | |
| $111.77 | $146.48 | $205.72 | +208% | Bullish | |
| $132.19 | $175.08 | $249.10 | +268% | Bullish | |
| $149.62 | $200.15 | $288.20 | +320% | Bullish | |
| $164.55 | $222.22 | $323.57 | +367% | Bullish | |
| $265.21 | $373.67 | $570.35 | +685% | Bullish | |
| $492.90 | $745.18 | $1,219.63 | +14.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $29.34 | $47.61 | $55.46 | +0.00% |
| August 2026 | $42.58 | $49.66 | $59.01 | +4.30% |
| September 2026 | $44.00 | $51.61 | $61.91 | +3.93% |
| October 2026 | $44.16 | $52.03 | $62.89 | +0.83% |
| November 2026 | $44.94 | $53.15 | $64.63 | +2.15% |
| December 2026 | $46.77 | $55.51 | $67.86 | +4.43% |
Click any year to see its month-by-month VCEL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect VCEL to range from $29.34 to $67.86 through 2026. The $47.61 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The VCEL price prediction for 2027 points to an average of $71.40 (low $58.52, high $91.03) — a potential gain of +50% on today's $47.61. Momentum favours further upside here.
In 2028, VCEL is projected to trade between $64.13 and $104.46, averaging $79.73 — a potential gain of +67% from today's $47.61. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Vericel Corporation's 2029 outlook centres on $97.07, within a $76.88 to $129.93 range. That is up +22% on the projected 2028 average. That marks a +104% change versus current levels. Momentum favours further upside here.
By 2030, VCEL could reach as high as $147.01, with a base case around $107.87 and support toward $84.28 — roughly +127% from $47.61. Buyers look set to stay in control over this stretch.
Expect VCEL to range from $89.76 to $161.04 through 2031. The $116.31 average target implies a +144% move from current prices. That is up +8% on the projected 2030 average. Momentum favours further upside here.
The VCEL price prediction for 2032 points to an average of $146.48 (low $111.77, high $205.72) — a potential gain of +208% on today's $47.61. Buyers look set to stay in control over this stretch.
In 2033, VCEL is projected to trade between $132.19 and $249.10, averaging $175.08 — a potential gain of +268% from today's $47.61. That is up +20% on the projected 2032 average. Momentum favours further upside here.
Vericel Corporation's 2034 outlook centres on $200.15, within a $149.62 to $288.20 range. That is up +14% on the projected 2033 average. That marks a +320% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, VCEL could reach as high as $323.57, with a base case around $222.22 and support toward $164.55 — roughly +367% from $47.61. Momentum favours further upside here.
Expect VCEL to range from $265.21 to $570.35 through 2040. The $373.67 average target implies a +685% move from current prices. That is up +68% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The VCEL price prediction for 2050 points to an average of $745.18 (low $492.90, high $1,219.63) — a potential gain of +14.7x on today's $47.61. Momentum favours further upside here.
Investing $1,000 in VCEL today (≈ 21.003991 VCEL) could be worth
$15,651.72
+$14,651.72 (+1465%) by 2050 · US Dollar
Based on the average projected VCEL price of $745.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VCELwould be worth at today's price.
$1,000 invested in VCEL on Jul 30, 2025 (≈ 24.594196 VCEL) would be worth
$1,170.93
+$170.93 (+17.1%) today · 1.17× · US Dollar
Based on a VCEL entry price of $40.66 vs. today's $47.61.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $45.05 | $1,056.83 | +5.7% |
| 1 month ago | $44.49 | $1,070.13 | +7.0% |
| 3 months ago | $35.57 | $1,338.49 | +33.8% |
| 6 months ago | $35.98 | $1,323.24 | +32.3% |
| 1 year ago | $40.66 | $1,170.93 | +17.1% |
| All time (5.0y) ago | $53.09 | $896.78 | -10.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VCEL forecast.
Our base-case forecast reaches $95.00 around 2029.
Implied market cap at $95.00: $4.85B
The multi-year forecast shows a rising trajectory in average prices from 2027 onward, with the 2026 average at $45.32 and a bullish tilt continuing through 2050. The yearly forecast averages climb to $66.34 (2027), $73.36 (2028), $88.08 (2029), $96.23 (2030), $102.50 (2031), $127.29 (2032), $150.64 (2033), $171.54 (2034), $189.11 (2035), $308.60 (2040), and $596.45 (2050). The corresponding ROI figures rise from 0% in 2026 to 46.4% (2027), 61.9% (2028), 94.3% (2029), 112.3% (2030), 126.2% (2031), 180.9% (2032), 232.4% (2033), 278.5% (2034), 317.3% (2035), 580.9% (2040), and 1,216.1% (2050).
Sentiment is BULLISH from 2027 onward. These are estimates and not guarantees. Drivers and risks are not itemized here beyond what is reflected in the forecast values.
Tap a question to reveal the answer.
Avg $96.23, min $74.78, max $132.06, ROI 112.3%, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with averages rising from $66.34 (2027) to $596.45 (2050) and ROI reaching 46.4% (2027) up to 1,216.1% (2050). For 2026 the avg is $45.32 with ROI 0 and a NEUTRAL sentiment.
Yes. The 2030 forecast max is $132.06, which is above $100, and earlier years also show substantial upside with higher max values (e.g., 2032 $180.23, 2033 $216.17, 2040 $476.26, 2050 $989.34).
Current price is $45.32 and market cap is $2.31B.
The 30-day range is $39.78 to $51.64 with support at $37.46 and resistance at $48.31. The sentiment is BULLISH, RSI is 50, SMA50 is $40.35 and SMA200 is $37.06.
Vericel Corporation Community Discussion
0Share your Vericel Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.